NYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-07-31
Reading PG? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Consumer Staples is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar broken — Maintain EPS growth between 1% and 6% in fiscal 2026: EPS growth 1.4% vs 1%.
View ThesisRevenue is growing steadily — about 3% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityManagement screens strong on capital allocation, earnings delivery, margins, the balance sheet.
View ManagementExpectations look high — the market is pricing in about 20% growth a year, above the roughly 3% analysts expect, leaving little room for error.
View ValuationRelatively steady — typically moves about 1% a day.
View RiskProcter & Gamble's growth must continue to justify its current price. Revenue grew 2% year over year, and the last quarter beat expectations. It trades at 21× P/E, above the peer median of 17×. The market is pricing in more growth than we forecast, making it look expensive. If PG cuts guidance on the next call, it could negatively impact the stock. Peer multiples imply a price about 19% below where it trades. This read is provisional.
Trailing returns as of 2026-07-31. PG is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 26 analysts currently covering PG (as of Jul 2026).
Based on 9 Wall Street analysts offering 12-month price targets for PG in the last 4 months.
A consensus fair price across 12 valuation methods, at three horizons. As of 2026-08-01. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Consumer Staples (broad) — fair value, gap to price, and forward P/E.
Weak earnings and macro risks could hinder growth objectives.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-07-31. EPS is implied from price ÷ P/E. Not investment advice.
Current $144.49
The last 12 months of price, then the range of analyst 12-month targets from today’s $144.49.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Threatens: Maintain adjusted free cash flow productivity of 85-90%
Cost hit may impact free cash flow productivity.
Threatens: Deliver organic sales growth of 1-3% in fiscal 2027
Downgrade indicates concerns over growth outlook.
Threatens: Deliver organic sales growth of 1-3% in fiscal 2027
Downgrade indicates potential growth challenges ahead.
Threatens: Sustain EPS growth outlook
EPS growth outlook is under pressure from cost headwinds.
Threatens: Maintain sales growth guidance
Sales miss indicates potential challenges to growth guidance.
Threatens: Maintain sales growth guidance
Profit decline and disappointing outlook impact sales growth guidance.
Advances: Sustain EPS growth outlook
Positive consumer response to innovation supports EPS growth outlook.
